| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/01/1990 | CA1268600A1 Molecules comprising at least one peptidic sequence carrying an epitope characteristic of a protein produced by cells infected with the malaria parasites and compositions comprising the same |
| 05/01/1990 | CA1268597A1 Diamino acid derivatives |
| 05/01/1990 | CA1268437A1 Method for purification of hbc antigen and method for measurement of hbc antibody by using said purified hbc antigen |
| 05/01/1990 | CA1268417A1 Intragonadal regulatory protein |
| 05/01/1990 | CA1268404A1 Polynucleotide assay reagent and method |
| 04/30/1990 | CA2001911A1 Albumin preparation and process for preparing the same |
| 04/30/1990 | CA2001787A1 Modified interleukin-2 and production thereof |
| 04/30/1990 | CA2001771A1 Sequence specific gene repressor |
| 04/29/1990 | CA2000717A1 Process for producing hemoglobin concentrate |
| 04/28/1990 | CA2360128A1 Phosphyorylated fusion proteins and uses related thereto |
| 04/28/1990 | CA2345497A1 Growth hormone variants and method for forming growth hormone variants |
| 04/27/1990 | CA2001629A1 Human leukocyte elastase inhibitors and methods of producing and using same |
| 04/27/1990 | CA2001343A1 Thrombolytic agents with modified kringle domains |
| 04/26/1990 | CA2001292A1 Isolation and cloning of complementary dna for gene coding of bovine trophoblast protein-1 |
| 04/25/1990 | EP0365468A1 Pharmaceutically active combination comprising a plasminogen activator and hirudin |
| 04/25/1990 | EP0365278A2 Protein purification process |
| 04/25/1990 | EP0365209A2 Anti-leu 3A amino acid sequence |
| 04/25/1990 | EP0364942A2 Isohirudine |
| 04/25/1990 | EP0364926A2 Activation of recombinant antibodies expressed in prokaryotes |
| 04/25/1990 | EP0364819A2 LHRH analogs |
| 04/25/1990 | EP0364778A1 Antibody against interleukin-1beta |
| 04/25/1990 | EP0364690A2 The alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 04/25/1990 | EP0364561A1 FACTOR VII/VIIa ACTIVE SITE INHIBITORS |
| 04/25/1990 | EP0364560A1 Diagnostic methods and systems for quantifying apo ai |
| 04/25/1990 | EP0364509A1 Cellular toxic conjugates |
| 04/25/1990 | EP0364493A1 Renin inhibiting peptides with nonpeptide linkages |
| 04/25/1990 | EP0364492A1 Virus proteins having reduced o-linked glycosylation |
| 04/25/1990 | EP0364481A1 Growth factors |
| 04/25/1990 | CA2001508A1 Nucleotide sequences expressing the adenyl cyclase of b. anthracis, proteins having the activity of this adenyl cyclase and biological uses |
| 04/25/1990 | CA2001320A1 Adenyl cyclase derivatives and biological uses of same |
| 04/24/1990 | US4920213 Method and compositions useful in preventing equine influenza |
| 04/24/1990 | US4920211 Mutated adenovirus E1A gene for E1A promoter stimulation |
| 04/24/1990 | US4920209 Oral vaccines |
| 04/24/1990 | US4920196 Human lymphotoxin |
| 04/24/1990 | US4920194 Blood substitute |
| 04/24/1990 | US4920144 Derivatives of bicyclic amino acids, agents containing them and their use as hypotensives |
| 04/24/1990 | US4919931 Method for producing ossein hydroxyapatite compound |
| 04/24/1990 | US4919930 Synthetic M proteins-streptococci type 5 |
| 04/24/1990 | US4919811 Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof |
| 04/24/1990 | CA2001239A1 Yeast heat shock protein 60 and analogs |
| 04/24/1990 | CA1268300A1 Method of somatotropin solubilization and naturation |
| 04/24/1990 | CA1268299A1 Chromogenic compounds, a process for their preparation and their use |
| 04/24/1990 | CA1268133A1 Strain of bacillus, obtaining a toxin thereof and a composition for combating coleoptera |
| 04/24/1990 | CA1268131A1 Polypeptide marker for alzheimer's disease and its use for diagnosis |
| 04/21/1990 | CA2001150A1 Composition and treament with biologically active peptides and certain anions |
| 04/21/1990 | CA2001128A1 Transgenic animals for testing multidrug resistance |
| 04/21/1990 | CA2001108A1 Drugs comprising a glycosylated interleukine-2 |
| 04/21/1990 | CA2001107A1 Process for the isolation of glycosylated interleukine-2 |
| 04/21/1990 | CA2001008A1 Cpf peptide compositions and uses |
| 04/20/1990 | CA2001094A1 Chemical compounds |
| 04/19/1990 | WO1990004176A1 THE RECEPTOR BINDING REGION OF EBVgp350 |
| 04/19/1990 | WO1990004076A1 Combination lock for blood identification system |
| 04/19/1990 | WO1990004041A1 Bacterial detection by phage transduction of detectable phenotype |
| 04/19/1990 | WO1990004036A1 Production of antibodies from transgenic animals |
| 04/19/1990 | WO1990004035A1 Recombinant pdgf and methods for production |
| 04/19/1990 | WO1990004032A1 A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins |
| 04/19/1990 | WO1990004030A1 Sequences of nucleotides coding for a protein having an ureasic activity |
| 04/19/1990 | WO1990004029A1 Melanin production |
| 04/19/1990 | WO1990004028A1 Recombinant polypeptides of the hemorragic septicemy virus of fish |
| 04/19/1990 | WO1990004026A1 New plasmid constructions for high level production of eukaryotic proteins |
| 04/19/1990 | WO1990004025A1 PROCESS FOR SCREENING AN EXPRESSION cDNA CLONE BANK FOR POLYNUCLEOTIDES |
| 04/19/1990 | WO1990004018A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 04/19/1990 | WO1990003985A1 A differentiation antigen, nda5, associated with amplification of differentiation of t and b lymphocytes |
| 04/19/1990 | WO1990003984A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
| 04/19/1990 | WO1990003983A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 04/19/1990 | WO1990003982A1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 04/19/1990 | WO1990003981A1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
| 04/19/1990 | WO1990003980A1 Therapeutic peptides |
| 04/19/1990 | WO1990003801A1 Vasopermeability-enhancing conjugates |
| 04/19/1990 | WO1990003798A2 Targetting agents |
| 04/19/1990 | WO1990003735A1 Methods and systems for producing hiv antigens |
| 04/19/1990 | WO1990003733A1 Osteogenic factors |
| 04/19/1990 | WO1990002808A3 Fermentation of genetically engineered yeast in the presence of a polyalkylene compound |
| 04/19/1990 | WO1990002801A3 Plants transformed with a dna sequence from bacillus thuringiensis lethal to lepidoptera |
| 04/19/1990 | DE3832785A1 Process for obtaining P adhesin |
| 04/19/1990 | CA2000850A1 Process for the purification of streptokinase |
| 04/18/1990 | EP0364344A2 Novel peptidase inhibitors |
| 04/18/1990 | EP0364255A2 Multiplex genomic DNA amplification for deletion detection |
| 04/18/1990 | EP0363792A1 Melanin production |
| 04/18/1990 | EP0363771A2 Production of hydrolysed proteins |
| 04/18/1990 | EP0363675A1 New derivatives of human/bovine basic fibroblast growth factor |
| 04/18/1990 | EP0363589A2 Somatostatin analogues |
| 04/18/1990 | EP0363436A1 Cloned protein g variant genes and the protein g variants expressed therefrom |
| 04/18/1990 | EP0363388A1 NUCLEAR ANTIGEN La |
| 04/18/1990 | EP0363386A1 Method to prepare a composition for treatment of amyotrophic lateral sclerosis |
| 04/18/1990 | CN1041392A Method for reduction of heterogeneity of monoclonal antibodies |
| 04/18/1990 | CA2000989A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
| 04/17/1990 | US4918747 Method and device for compensating, in a coherent optical communication system with heterodyne detection, at the receiving side, phase noise of a transmitting laser and of a local laser |
| 04/17/1990 | US4918166 Particulate hybrid HIV antigens |
| 04/17/1990 | US4918163 Medical diagnosis; infection treatment |
| 04/17/1990 | US4918162 Identifiying neural or lung cancer in human patients |
| 04/17/1990 | US4918161 Low molecular weight pulmonary surfactant proteins |
| 04/17/1990 | US4918055 Method of stimulating melanocytes by topical application of analogs of alpha-MSH, and compositions for use in same |
| 04/17/1990 | US4918054 Antibiotics called `chloropolysporins B and C`, a process for their preparation, and their therapeutic and veterinary use |
| 04/17/1990 | US4918015 Gentamicin-resistance genes and their use as markers |
| 04/17/1990 | US4918014 Method for producing mucoid and phage resistant group N streptococcus strains from non-mucoid and phage sensitive parent strains |
| 04/17/1990 | US4918008 Enzymatic decomposition of whey proteins, lactalbumin lactoglobulin, lysozyme, lactoferrin or serum albumin; used as ointment, analgesics, antiflammatory |
| 04/17/1990 | US4918007 Gene expression to produce proteins |
| 04/17/1990 | US4918006 Recombinant plasmids containing larvicide endotoxin gene; bacillus |
| 04/17/1990 | US4917998 Reaction product of body fluid with monoclonal antibody |